Gene · 51430
Papers1,981
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,981
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CH1-specific affinity resins possess the potential of separating heterodimer from homodimers in asymmetric bispecific antibody purification. | J Biol Methods | 2024 | 39544192 | PubTator, text mining | PubMed |
| A new QRS detector stress test combining temporal jitter and F-score (JF) reveals significant performance differences amongst popular detectors. | PLoS One | 2024 | 39527567 | PubTator, text mining | PubMed |
| VCAb: a web-tool for structure-guided exploration of antibodies. | Bioinform Adv | 2024 | 39399372 | PubTator, text mining | PubMed |
| Predictive Model Building for Aggregation Kinetics Based on Molecular Dynamics Simulations of an Antibody Fragment. | Mol Pharm | 2024 | 39348223 | PubTator, text mining | PubMed |
| Development and Test of Low-Cost Multi-Channel Multi-Frequency Lock-In Amplifier for Health and Environment Sensing. | Sensors (Basel) | 2024 | 39338765 | PubTator, text mining | PubMed |
| Developability considerations for bispecific and multispecific antibodies. | MAbs | 2024 | 39189686 | PubTator, text mining | PubMed |
| Dissecting phospho-motif-dependent Shc1 interactome using long synthetic protein fragments. | Chem Sci | 2024 | 39184293 | PubTator, text mining | PubMed |
| Dimitriou M, Mortera-Blanco T, Tobiasson M, et al. Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation. Blood. 2024;143(11):953-966. | Blood | 2024 | 39052273 | PubTator, text mining | PubMed |
| Automated neuronal reconstruction with super-multicolour Tetbow labelling and threshold-based clustering of colour hues. | Nat Commun | 2024 | 38918382 | PubTator, text mining | PubMed |
| Immunoglobulin constant regions provide stabilization to the paratope and enforce epitope specificity. | J Biol Chem | 2024 | 38763332 | PubTator, text mining | PubMed |
| Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions. | MAbs | 2024 | 38666503 | PubTator, text mining | PubMed |
| Can antibodies be "vegan"? A guide through the maze of today's antibody generation methods. | MAbs | 2024 | 38634488 | PubTator, text mining | PubMed |
| A novel robust evaluation approach to improve systematic behavior of failure safety in water supply system under various ellipsoid uncertainties. | Sci Rep | 2024 | 38627554 | PubTator, text mining | PubMed |
| A model free method of predicting transient dynamics in anaerobic digestion. | J R Soc Interface | 2024 | 38531409 | PubTator, text mining | PubMed |
| Sarcomeric tropomyosin expression during human iPSC differentiation into cardiomyocytes. | Cytoskeleton (Hoboken) | 2024 | 38470291 | PubTator, text mining | PubMed |
| Active coexistence of the novel gammaproteobacterial methanotroph 'Ca. Methylocalor cossyra' CH1 and verrucomicrobial methanotrophs in acidic, hot geothermal soil. | Environ Microbiol | 2024 | 38454738 | PubTator, text mining | PubMed |
| High Frequencies of Genetic Variants in Patients with Atypical Femoral Fractures. | Int J Mol Sci | 2024 | 38396997 | PubTator, text mining | PubMed |
| CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges. | Heliyon | 2024 | 38390187 | PubTator, text mining | PubMed |
| Design and engineering of bispecific antibodies: insights and practical considerations. | Front Bioeng Biotechnol | 2024 | 38333084 | PubTator, text mining | PubMed |
| Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population. | Nat Commun | 2024 | 38307854 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51430/papers?page=5